YOLFTbeta
Vitrafy Life Sciences Ltd

Vitrafy Life Sciences Ltd

VFY · AU · Technology / Software - Infrastructure

2.30AUD+0.13 (+5.99%)

Price History

Full chart

Market Stats

Previous Close2.17
Open2.27
Day Range2.21 – 2.30
52-Week Range1.20 – 4.66
Volume1.40M
Market Cap266.84M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.26
Dividend Yield0.00%
50-Day Avg3.76
200-Day Avg2.57

About

Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. It offers cryopreservation medical devices, including freezers, thawers, and packaging solutions. The company also provides the LifeChain software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials, as well as the Guardion, non-medical hardware device. Its cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs. Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia.

Company Details

  • SectorTechnology
  • IndustrySoftware - Infrastructure
  • CEOMr. Brenton Michael Leslie Owens
  • Employees0
  • Headquarters385 Bourke Street, Melbourne, VIC, Australia, 3000, Australia
  • Websitehttps://www.vitrafy.com

Leadership

  • Mr. Brenton Michael Leslie OwensCo-Founder, MD, CEO & Executive Director
  • Mr. Simon Thomas MartinChief Financial Officer
  • Dr. Heather PidcokeChief Science Officer
  • Mr. Michael Sapountzis AGIA, B.Com., L.L.B., M.A.I.C.D.Company Secretary

Financials

Income Statement

Currency: AUD2022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue-32.00K37.00K65.11K168.73K
Growth (%)--+15.63%+75.98%+159.13%
Gross Profit-32.00K37.00K65.11K168.73K
Gross Margin-100.00%100.00%100.00%100.00%
Operating Expense-9.20M10.71M16.63M20.61M
Operating Income-6.44M-9.16M-10.67M-16.57M-20.44M
Operating Margin--28640.63%-28835.14%-25446.66%-12112.46%
EBITDA--2.82M7.00K-26.06M-16.04M
EBITDA Margin--8812.50%18.92%-40029.71%-9508.80%
Net Income-7.66M-7.81M-10.43M-32.71M-16.17M
Net Income Margin--24415.63%-28175.68%-50237.25%-9584.18%
R&D1.28M4.18M4.25M6.56M-
R&D as % of Total Revenue-13059.38%11481.08%10080.29%-
Interest Expense2.73M4.99M10.43M6.49M2.64K
Interest Expense % of Total Revenue-15603.13%28194.59%9970.91%1.57%

Balance Sheet

Currency: AUD2022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets0041.33M31.84M43.21M
Total Liabilities001.34M3.08M2.10M
Total Equity0039.99M28.77M41.11M
Cash--37.97M19.52M26.10M

Cash Flow

Currency: AUD2022-06-302023-06-302024-06-302025-06-302026-06-30
Financing Cash Flow-58.00K5.80M11.50M31.99M27.88M
Capital Expenditure486.00K90.00K13.00K1.85K537.36K
Free Cash Flow-6.36M-5.05M-6.80M-8.80M-16.31M

Key Statistics & Ratios

Market Cap266.84M
Enterprise Value221.40M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1276.77
Price / Book6.38
EPS-0.26
Book Value0.545
Revenue (TTM)209.00K
Gross Profit (TTM)-8.46M
EBITDA-16.73M
Profit Margin0.00%
Operating Margin522.50%
Return on Equity-46.29%
Return on Assets-27.94%
Shares Outstanding76.24M
Shares Float50.62M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%